Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD

NCT03781752 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT03781752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03781752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Phase 4
Overall status
Recruiting
Start date
March 4, 2018
Completion date
August 31, 2025
Enrollment
500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, attention deficit hyperactivity disorder